Please Wait.....
Report
United Kingdom Cardiovascular Devices - Market Share Analysis, Industry Trends & Statistics, Growth Forecasts (2025 - 2030)
Market Report I 2025-07-01 I 110 Pages I Mordor Intelligence
United Kingdom Cardiovascular Devices Market Analysis
The UK cardiovascular devices market size is USD 2.55 billion in 2025 and is projected to reach USD 3.48 billion by 2030, expanding at a 6.45% CAGR during the forecast period. Robust NHS capital funding, virtual ward roll-outs and rapid uptake of AI-enabled diagnostics are sustaining momentum even as post-Brexit regulatory duplication adds cost and complexity. Demand is concentrating around minimally invasive systems that shorten hospital stays, with transcatheter valve and pulsed-field ablation platforms becoming mainstay therapies. Supply-chain pressures have encouraged domestic manufacturing initiatives, while sustainability mandates are spurring investment in recyclable single-use catheters. Competitive dynamics remain intense, with strategic acquisitions and AI-centric product launches reshaping technology leadership.
United Kingdom Cardiovascular Devices Market Trends and Insights
NHS Long-Term Plan Funding Boost for Cardiac Networks Accelerating Device Adoption
Targeted investments channelled through the GBP 25.7 billion NHS uplift for 2024-2025 are modernising cardiac networks and enabling faster technology rotation . Allocating GBP 1.5 billion to surgical hubs and GBP 70 million to advanced radiotherapy suites gives trusts the capacity to clear procedure backlogs while integrating novel devices. The NHS 10-Year Plan ties procurement to measurable outcomes, favouring vendors with strong clinical-evidence files. Integrated care systems encourage cross-trust purchasing, increasing order volumes and shortening adoption cycles by up to two years. These funding streams thus reinforce first-mover advantages for innovators with proven value propositions.
Rapid Uptake of Remote Cardiac Monitoring under NHS "Virtual Wards" Programme
NHS England aims to deliver 50,000 virtual-ward beds by 2025, fundamentally redesigning cardiac care pathways. Early pilots such as the Northern Care Alliance's 500-bed model cut acute admissions by 30%, validating the service design at scale. NICE guidance endorsing HeartLogic and TriageHF technologies, which reduce heart-failure hospitalisations by up to 72%, further underpins rapid diffusion. Academic studies at Imperial College Healthcare show 76% fewer readmissions when tele-monitoring complements standard therapy. Savings of GBP 1,958 per patient strengthen the business case, opening new revenue channels for device makers aligned with NHS digital architecture.
High Failure-Recall Rates of Certain Stent Models Eroding Clinician Confidence
Class I recalls involving Boston Scientific's Accolade pacemakers and Abbott's Assurity series have shaken trust, prompting closer scrutiny of new technologies. MHRA reforms effective June 2025 demand active surveillance and faster incident reporting, raising compliance costs and delaying launches. Adverse publicity extends beyond recalled SKUs, dampening uptake across adjacent product categories. Clinicians now seek extensive post-market data before switching platforms, lengthening sales cycles and elevating barriers for SMEs.
Other drivers and restraints analyzed in the detailed report include:
Growing Backlog of Elective Cardiac Procedures Driving Shift to Minimally Invasive Devices / Increasing Prevalence of Atrial Fibrillation in Ageing UK Population Raising Demand for Rhythm-Management Devices / NHS Workforce Shortage Constraining Equipment Replacement Cycles /
For complete list of drivers and restraints, kindly check the Table Of Contents.
Segment Analysis
Therapeutic and surgical platforms generated 58.20% of 2024 revenues, sustained by well-resourced cardiac centres performing high-value interventions. Uptake of ultrathin drug-eluting stents and TAVR systems illustrates how procedural efficiency steers purchasing decisions. Abbott's AVEIR leadless pacemaker, now under breakthrough-device designation, shows the innovation premium vendors can command .
Diagnostic and monitoring solutions, though smaller today, are projected to grow at a 6.98% CAGR through 2030 as prevention and remote care take centre stage. AI-enabled ECG devices that rival 12-lead hospital units underscore this momentum. Virtual-ward expansion embeds remote telemetry in standard care pathways, lifting recurring revenue from cloud analytics. Consequently, the UK cardiovascular devices market size for diagnostics is on path to outstrip therapeutics in growth pace, reshaping revenue mixes over the decade.
The UK Cardiovascular Devices Market Report is Segmented by Product Type (Diagnostic & Monitoring Devices, Therapeutic & Surgical Devices), Application (Coronary Artery Disease, Arrhythmia & Conduction Disorders, Heart Failure & Cardiomyopathy, Structural & Congenital Heart Defects, and More), End User (Hospitals & Cardiac Centres, Ambulatory Surgical Centres, and More). The Market Forecasts are Provided in Terms of Value (USD).
List of Companies Covered in this Report:
Medtronic / Abbott Laboratories / Boston Scientific / Edward Lifesciences / Koninklijke Philips / Siemens Healthineers / Johnson & Johnson (Biosense Webster & Cordis) / GE Healthcare Technologies Inc. / Terumo / B. Braun / BIOTRONIK / LivaNova / MicroPort / Cook Group / W. L. Gore & Associates / Getinge AB (Maquet) / Merit Medical Systems / Shockwave Medical Inc. / Penumbra / SynCardia Systems / Nipro / Corin Group PLC /
Additional Benefits:
The market estimate (ME) sheet in Excel format /
3 months of analyst support /
1 Introduction
1.1 Study Assumptions & Market Definition
1.2 Scope of the Study
2 Research Methodology
3 Executive Summary
3.1 Market Landscape
3.2 Market Overview
3.3 Market Drivers
3.3.1 NHS Long-Term Plan Funding Boost for Cardiac Networks Accelerating Device Adoption
3.3.2 Rapid Uptake of Remote Cardiac Monitoring under NHS "Virtual Wards" Programme
3.3.3 Growing Backlog of Elective Cardiac Procedures Driving Shift to Minimally Invasive Devices
3.3.4 Increasing Prevalence of Atrial Fibrillation in Ageing UK Population Raising Demand for Rhythm Management Devices
3.3.5 Government Procurement Frameworks Favouring Environmentally Sustainable Single-Use Catheters
3.3.6 Post-Brexit Regulatory Duplication Increasing Approval Costs for SMEs
3.4 Market Restraints
3.4.1 High Failure-Recall Rates of Certain Stent Models Eroding Clinician Confidence
3.4.2 NHS Workforce Shortage Constraining Equipment Replacement Cycles
3.4.3 Import-led Inflation Raising ASPs of High-tech Devices Post-Brexit
3.4.4 UKCA Certification Uncertainty Deterring SME Product Launches
3.5 Value/ Supply-Chain Analysis
3.6 Regulatory Landscape
3.7 Technological Outlook
3.8 Porter's Five Forces
3.8.1 Threat of New Entrants
3.8.2 Bargaining Power of Suppliers
3.8.3 Bargaining Power of Buyers
3.8.4 Threat of Substitutes
3.8.5 Competitive Rivalry
4 Market Size & Growth Forecasts (Value)
4.1 By Product Type
4.1.1 Diagnostic & Monitoring Devices
4.1.1.1 ECG Systems
4.1.1.2 Remote Cardiac Monitor
4.1.1.3 Cardiac MRI
4.1.1.4 Cardiac CT
4.1.1.5 Echocardiography / Ultrasound
4.1.1.6 Fractional Flow Reserve (FFR) Systems
4.1.2 Therapeutic & Surgical Devices
4.1.2.1 Coronary Stents
4.1.2.1.1 Drug-Eluting Stents
4.1.2.1.2 Bare-Metal Stents
4.1.2.1.3 Bioresorbable Stents
4.1.2.2 Catheters
4.1.2.2.1 PTCA Balloon Catheters
4.1.2.2.2 IVUS/OCT Catheters
4.1.2.3 Cardiac Rhythm Management
4.1.2.3.1 Pacemakers
4.1.2.3.2 Implantable Cardioverter Defibrillators
4.1.2.3.3 Cardiac Resynchronization Therapy Devices
4.1.2.4 Heart Valves
4.1.2.4.1 TAVR/TAVI
4.1.2.4.2 Mechanical Valves
4.1.2.4.3 Tissue/Bioprosthetic Valves
4.1.2.5 Ventricular Assist Devices
4.1.2.6 Artificial Hearts
4.1.2.7 Grafts & Patches
4.1.2.8 Other Cardiovascular Surgical Devices
4.2 By Application
4.2.1 Coronary Artery Disease
4.2.2 Arrhythmia & Conduction Disorders
4.2.3 Heart Failure & Cardiomyopathy
4.2.4 Structural & Congenital Heart Defects
4.2.5 Peripheral Vascular Disease
4.3 By End User
4.3.1 Hospitals & Cardiac Centres
4.3.2 Ambulatory Surgical Centres
4.3.3 Cardiology/EP Clinics
4.3.4 Home-care & Remote Monitoring Programs
5 Competitive Landscape
5.1 Market Concentration
5.2 Market Share Analysis
5.3 Company Profiles {(includes Global level Overview, Market level overview, Core Segments, Financials as available, Strategic Information, Market Rank/Share for key companies, Products & Services, and Recent Developments)}
5.3.1 Medtronic plc
5.3.2 Abbott Laboratories
5.3.3 Boston Scientific Corporation
5.3.4 Edwards Lifesciences Corporation
5.3.5 Koninklijke Philips N.V. (Philips Healthcare)
5.3.6 Siemens Healthineers AG
5.3.7 Johnson & Johnson (Biosense Webster & Cordis)
5.3.8 GE Healthcare Technologies Inc.
5.3.9 Terumo Corporation
5.3.10 B. Braun Melsungen AG
5.3.11 Biotronik SE & Co. KG
5.3.12 LivaNova PLC
5.3.13 MicroPort Scientific Corporation
5.3.14 Cook Medical LLC
5.3.15 W. L. Gore & Associates Inc.
5.3.16 Getinge AB (Maquet)
5.3.17 Merit Medical Systems Inc.
5.3.18 Shockwave Medical Inc.
5.3.19 Penumbra Inc.
5.3.20 SynCardia Systems LLC
5.3.21 Nipro Corporation
5.3.22 Corin Group PLC
6 Market Opportunities & Future Outlook
6.1 White-Space & Unmet-Need Assessment
- Not Sure / Need Reassuring
- Confirm Content
-
Content is provided by our partners and every effort is made to make Market Report details as clear as possible. If you are not sure the exact content you require is included in this study you can Contact us to double check. To do this you can:
Use the ‘? ASK A QUESTION’ below the license / prices and to the right of this box. This will come directly to our team who will work on dealing with your request as soon as possible.
Write to directly on support@scotts-international.com with details. Please include as much information as possible including the name of report or link so our staff will be able to work on you request.
Telephone us directly on 0048 603 394 346 and an experienced member of team will be on hand to answer.
-
- Sample Pages
-
With the vast majority of our partners we can obtain Sample Pages to support your decision. This is something we can arrange without revealing your personal details.
It is important to note that we will not be able to provide you the exact data or statistics such as Market Size and Forecasts. Sample pages usually confirm the layout or the Categories included in Charts and Graphs, excluding specific data.
To ask for Sample Pages by contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Check for Alternatives
-
Whilst we try to make our online platform as easy to use as possible there is always the possibility that a better alternative has not been found in your search.
To avoid this possibility Contact us through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346 and a Senior Team Member can review your requirements and send a list of possibilities with opinions and recommendations.
-
- Confirm Content
- Prices / Formats / Delivery
- Prices
-
All prices are set by our partners and should be exactly the same as those listed on their own websites. We work on a Revenue share basis ensuring that you never pay more than what is offered elsewhere.
Should you find the price cheaper on another platform we recommend you to Contact us as we should be able to match this price. You can Contact us though through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Discounts
-
As we work in close partnership with our Partners from time to time we can secure discounts and assist with negotiations, this is part of our personalised service to you.
Discounts can sometimes be arranged for speedily placed orders; multiple report purchases or Higher License purchases.
To check if a Discount is possible please Contact our experienced team through ‘? ASK A QUESTION’, support@scotts-international.com, or by telephoning 0048 603 394 346.
-
- Available Currencies
-
Most Market Reports on our platform are listed in USD or EURO based on the wishes of our Partners. To avoid currency fluctuations and potential price differentiations we do not offer the possibility to change the currency online.
Should you wish to pay in a different currency to that advertised online we do accept payments in USD, EURO, GBP and PLN. The price will be calculated based on the relevant exchange rate taken from our National Bank.
To pay in a different above currency to that advertised online please Contact our team and a quotation will be sent within a couple of hours with payment details.
-
- Licenses
-
License options vary from Partner to Partner as is usually based on the number of Users that will benefitting from the report. It is very important that License ordered is not breached as this could have potential negative consequences for you individually or your employer.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Global Site License
-
The Global Site License is the most comprehensive license available. By selecting this license, the Market Report can be shared with other ‘Allowed Users’ and any other member of staff from the same organisation regardless of geographic location.
It is important to note that this may exclude Parent Companies or Subsidiaries.
If you have questions or need confirmation about the specific license we recommend you to Contact us and a detailed explanation will be provided.
-
- Formats
-
The most common format is PDF, however in certain circumstances data may be present in Excel format or Online, especially in the case of Database or Directories. In addition, for certain higher license options a CD may also be provided.
If you have questions or need clarification about the specific formats we recommend you to Contact us and a detailed explanation will be provided.
-
- Delivery
-
Delivery is fulfilled by our partners directly. Once an order has been placed we inform the partner by sharing the delivery email details given in the order process.
Delivery is usually made within 24 hours of an order being placed, however it may take longer should your order be placed prior to the weekend or if otherwise specified on the Market Report details page. Additionally, if details have been not fully completed in the Order process a delay in delivery is possible.
If a delay in delivery is expected you will be informed about it immediately.
-
- Shipping Charges
-
As most Market Reports are delivered in PDF format we almost never have to add additional Shipping Charges. If, however you are ordering a Higher License service or a specific delivery format (e.g. CD version) charges may apply.
If you are concerned about additional Shipping Charges we recommend you to Contact us to double check.
-
- Prices
- Ordering
- By Credit Card
-
We work in Partnership with PayU to ensure payments are made securely in a fast and effortless way. PayU is the e-payments division of Naspers.
Naspers operates in over 133 International Markets and ranks 3rd Globally in terms of the number of e-commerce customers served.
For more information on PayU please visit: https://www.payu.pl/en/about-us
-
- By Money Transfer
-
If you require an invoice prior to payment, this is possible. To ensure a speedy delivery of the Market Report we require all relevant company details and you agree to maximum payment terms of 30 days from receipt of order.
With our regular clients deliver of the Market Report can be made prior to receiving payment, however in some circumstances we may ask for payment to be received before arranging for the Market Report to be delivered.
-
- By Credit Card
- Security
- Website security
-
We have specifically partnered with leading International companies to protect your privacy by using different technologies and processes to ensure security.
Everything submitted to Scotts International is encrypted via SSL (Secure Socket Layer) and all personal information provided to Scotts International is stored on computer systems with limited access in controlled environments.
-
- Credit Card Security
-
We partner with PayU (https://www.payu.pl/en/about-us) to ensure all credit card payments are made securely in a fast and effortless way.
PayU offers 250+ various payment channels and eWallet services across 4 continents allowing buyers to pay electronically, whether on a computer or a mobile device.
-
- Website security